Literature DB >> 11984806

Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.

A Y N Schouten-Van Meeteren1, A C Moll, S M Imhof, A J P Veerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11984806     DOI： 10.1002/mpo.1358

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


× No keyword cloud information.
  4 in total

1.  Thermochemotherapy in hereditary retinoblastoma.

Authors:  A O Schueler; C Jurklies; H Heimann; R Wieland; W Havers; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.

Authors:  Jeannette R Wong; Lindsay M Morton; Margaret A Tucker; David H Abramson; Johanna M Seddon; Joshua N Sampson; Ruth A Kleinerman
Journal:  J Clin Oncol       Date:  2014-09-02       Impact factor: 44.544

Review 3.  Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

Authors:  Eleanor M Pritchard; Michael A Dyer; R Kiplin Guy
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

4.  Treatment of retinoblastoma: current status and future perspectives.

Authors:  Carlos Rodriguez-Galindo; Guillermo L Chantada; Barrett G Haik; Matthew W Wilson
Journal:  Curr Treat Options Neurol       Date:  2007-07       Impact factor: 3.598
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.